This change is accompanied by an upregulation of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), further enhancing the anti-tumor immune response. The gene discussed is IL6; the disease is neoplasm.